Profiles of Drug Substances, Excipients and Related Methodology

Profiles of Drug Substances, Excipients and Related Methodology

Author: Harry G. Brittain

Publisher: Academic Press

Published: 2011-07-15

Total Pages: 399

ISBN-13: 0123877024

DOWNLOAD EBOOK

Volumes in this widely revered series present comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. This organizational structure meets the needs of the pharmaceutical community and allows for the development of a timely vehicle for publishing review materials on this topic. The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodology related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients. - Presents comprehensive reviews covering all aspects of drug development and formulation of drugs - Profiles creatine monohydrate and fexofenadine hydrochloride, as well as five others - Meets the information needs of the drug development community


NUCYNTA ER Drug Profile, 2023

NUCYNTA ER Drug Profile, 2023

Author: DrugPatentWatch

Publisher: DrugPatentWatch.com

Published: 2023-08-15

Total Pages: 153

ISBN-13: 1934899631

DOWNLOAD EBOOK

NUCYNTA ER Drug Profile, 2023

This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


Analytical Profiles of Drug Substances and Excipients

Analytical Profiles of Drug Substances and Excipients

Author:

Publisher: Academic Press

Published: 1994-09-05

Total Pages: 625

ISBN-13: 0080861180

DOWNLOAD EBOOK

Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Edited by the Associate Director of Analytical Research and Development for the AmericanAssociation of Pharmaceutical Scientists, Analytical Profiles of Drug Substances and Excipients brings this information together into one source. The scope of the series has recently been expanded to include profiles of excipient materials.


NAMZARIC Drug Profile, 2023

NAMZARIC Drug Profile, 2023

Author: DrugPatentWatch

Publisher: DrugPatentWatch.com

Published: 2023-08-15

Total Pages: 114

ISBN-13: 1934899704

DOWNLOAD EBOOK

NAMZARIC Drug Profile, 2023

This report focuses on NAMZARIC and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


Masterpieces of Swiss Entrepreneurship

Masterpieces of Swiss Entrepreneurship

Author: Jean-Pierre Jeannet

Publisher: Springer Nature

Published: 2021-04-21

Total Pages: 579

ISBN-13: 3030652874

DOWNLOAD EBOOK

This open access book focuses on Switzerland-based medium-sized companies with a longstanding export tradition and a proven dominance in global niche markets. Based upon in-depth documentation and analysis of 36 Swiss companies over their entire history, an expert team of authors presents several parallels in the pathways and success factors which allowed these firms to become dominant and operate from a high-cost location such as Switzerland. The book enhances these insights by providing detailed company profiles documenting the company history, development, and how their relevant global niche positions were reached. Readers will benefit from these profiles as they compile a diverse selection of industries, mainly active within the B2B sector, with mostly mature companies (60 years to older than 100 years since founding) and different types of ownership structures including family firms. ‘Masterpieces of Swiss Entrepreneurship’ brings unique learning opportunities to owners and leaders of SMEs in Switzerland and elsewhere. Findings are based on detailed bottom-up research of 36 companies -- without any preconceived notions. The book is both conceptual and practical. It fosters understanding for different choices in development pathways and management practices. Matti Alahuhta, Chairman DevCo Partners, ex-CEO Kone, Board member of several global listed companies, Helsinki, Finland Start-up entrepreneurs need proven models from industry which demonstrate the various paths to success. “Masterpieces of Swiss Entrepreneurship” provides deep insights highlighting these models and the important trade-offs entrepreneurial teams must consider when choosing the path of high growth or of maximum control, as they are often mutually exclusive. Gina Domanig, Managing Partner, Emerald Technology Ventures, Zurich


Profile of the International Membrane Industry - Market Prospects to 2008

Profile of the International Membrane Industry - Market Prospects to 2008

Author: K Sutherland

Publisher: Elsevier

Published: 2003-12-18

Total Pages: 185

ISBN-13: 008051507X

DOWNLOAD EBOOK

The definitive guide to the international membrane industry. - Will help you to keep track of the major issues affecting the fast growing membrane market - Will enable you to identify new business opportunities - Includes Market forecasts, commentary and analysis supported by primary research Completely revised and updated, the 3rd edition of Profile of the International Membrane Industry - Market Prospects to 2008 reviews the markets, technological trends and major manufacturers of industrial membranes. We have drawn on the expertise from our existing portfolio, Membrane Technology newsletter and Filtration & Separation magazine to bring you vital information, analyses and forecasts that cannot be found anywhere else. The report covers all industrial applications involving both liquid and gas separation, including: - Microfiltration - Ultrafiltration - Reverse osmosis and nanofiltration - All other membrane separations The study deals with all kinds of separating media that are now accepted as membranes, whether they are polymeric, ceramic, metallic or liquid. In broad terms the study covers microfiltration, ultrafiltration, reverse osmosis and nanofiltration and all other membrane separations. Profile of the International Membrane Industry covers the structure of the industry, highlighting developments, identifying future trends, and looking at recent mergers and acquisitions in the sector. Market estimates and forecasts to 2008, by region and membrane type, are presented along with an analysis of the main end-user markets for industrial membranes, and a technology overview. Forty leading international membrane manufacturers are profiled. A directory of membrane manufacturing companies is also included.


XIFAXAN Drug Profile, 2023

XIFAXAN Drug Profile, 2023

Author: DrugPatentWatch

Publisher: DrugPatentWatch.com

Published: 2023-08-15

Total Pages: 219

ISBN-13: 1934899518

DOWNLOAD EBOOK

XIFAXAN Drug Profile, 2023

This report focuses on XIFAXAN and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


How to Break Into Pharmaceutical Sales

How to Break Into Pharmaceutical Sales

Author: Tom Ruff

Publisher: Tom Ruff Company

Published: 2007

Total Pages: 236

ISBN-13: 0978607015

DOWNLOAD EBOOK

[This book is an] organized 'formulary' written for those who are considering a specific field - 'drug reps', as they are known in the industry.-Introd.